University of Iowa
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Iowa sits in the top decile of US sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count).
University of Iowa: 228 sponsored US clinical trials, 28 recruiting.
University of Iowa sponsors 228 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 156 completed. 23 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 6 trials.
Top-decile sponsor footprint
University of Iowa ranks in the top decile of sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 184 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
228 total, page 5 of 5
Study of How An Ankle Strap Changes Effects of Insole Treatment for Knee Osteoarthritis
NCT00331110
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
NCT00574470
Atomoxetine and Huntington's Disease
NCT00368849
Citalopram to Enhance Cognition in HD
NCT00271596
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer
NCT00245349
Essential Fatty Acids for Major Depression
NCT00256412
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
NCT00574964
Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study
NCT00581893
Trial of Aripiprazole in the Treatment of CD in Adolescents
NCT00250705
Determination of Amifostine Levels During Radiation Therapy
NCT00286611
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
NCT00233506
Randomized Trial Of Tinnitus Retraining Therapy
NCT00578058
Improving Adherence to Blood Pressure Guidelines
NCT00201019
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
NCT00585052
Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment
NCT00565305
Team Management of High Blood Pressure
NCT00201045
Trental & Vitamin E for Radiation-Induced Fibrosis
NCT00583700
Bupropion in the Treatment of Pathological Gambling
NCT00055393
Treatment for Borderline Personality Disorder
NCT00055315
Treatment for Early Memory Loss
NCT00042172
Genetic Risk Assessment of Defibrillator Events
NCT02045043
Sleep and Circadian Rhythms in Mechanically Ventilated Patients
NCT01276652
Magnetic Stimulation Therapy for Treating Vascular Depression
NCT00044798
Clinician Managed Interpersonal Psychotherapy
NCT00043602
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
NCT00583102
Trial of Non-invasive Ventilation for Stable COPD
NCT01722773
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
NCT00010452
Investigation of Dried Plums in the Treatment of Adults With Constipation
NCT01180725
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 22 |
| Phase 2 | 27 |
| Phase 3 | 4 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Iowa pipeline
28 recruiting of 228 indexed (12% open); 156 completed (68%).
Phase mix: 23 late (III/IV) vs 49 early (I/II) (early-phase heavy).
Top condition: Healthy (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Iowa: open-pipeline peers nationwide
Peers matched on 228 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Iowa sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 228 trials (± recruiting share)
- Georgetown University · 227 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Brown University · 231 trials · 15% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Daiichi Sankyo · 12% recruiting · 236 trials
- Augusta University · 12% recruiting · 106 trials
- National Institute of Mental Health (NIMH) · 12% recruiting · 343 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this University of Iowa page
228 registered trials is a research-attention snapshot, not an endorsement of University of Iowa or any single study.
- 28 of University of Iowa's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Iowa studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Iowa pipeline card: 228 registered trials from official public datasets.Report a data error.